Clinical Trial Update: Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

AZD5305 is being evaluated as a monotherapy and in combination with anti-cancer agents in a Phase 1/2 trial for multiple advanced solid malignancies, with the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• AZD5305 (AZD5305)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer, Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING